Picture of aap Implantate AG logo

AAQ1 aap Implantate AG News Story

0.000.00%
de flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapNeutral

Brief: Aap Implantate: Q1 Sales Up 6% At EUR 2.9 Mln

May 13 (Reuters) - AAP IMPLANTATE AG  AAQ1k.DE :
    * Q1/2022: SOLID START TO THE YEAR WITH 6 % SALES GROWTH AND
EBITDA WITHIN EXPECTATIONS IN A CHALLENGING MACROECONOMIC
ENVIRONMENT
    * Q1 SALES ROSE 6 PERCENT TO 2.9 MILLION EUR
    * Q1 SALES: EUR 2.9 MILLION (+6 % YOY); EMEA (+19 % YOY) AND
NORTH
AMERICA (+5 % YOY) AS MAIN GROWTH DRIVERS
    * Q1 EBITDA: EUR -0.5 MILLION (Q1/2021: EUR -0.2 MILLION)
IMPACTED
BY PLANNED BUILD-UP OF SALES INFRASTRUCTURE AND CONDUCTION OF
HUMAN CLINICAL STUDY
    * CONTINUES FOR TIME BEING TO ADHERE TO COMMUNICATED
FORECAST
VALUES FOR SALES AND EBITDA FOR FINANCIAL YEAR 2022.

Source text for Eikon:  ID:nEQc8SMLa 
Further company coverage:  AAQ1k.DE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

Recent news on aap Implantate AG

See all news